TAAR1 and ovarian cancer: Ovarian cancer patients with enhanced TAAR1 expression in the membrane and/or cytoplasm (IRS > 3) (n = 69) have a significantly longer overall survival (OS) than patients with a low TAAR1 expression (IRS ≤ 3) (n = 64), as shown in the Kaplan-Meier curve in Figure 5 (p = 0.045).